The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
Efficacy, safety, pharmacokinetic (PK), and pharmacodynamic (PD) support for talquetamab (tal) QW and Q2W dosing in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Analyses from MonumenTAL-1.
 
Xuewen Ma
Employment - Johnson & Johnson/Janssen; Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Jue Gong
No Relationships to Disclose
 
Jie Zhou
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Dongfen Yuan
Employment - Janssen Research & Development
Stock and Other Ownership Interests - AstraZeneca; Janssen Research & Development; Moderna Therapeutics (I)
Patents, Royalties, Other Intellectual Property - BIOLOGICAL AGENT-EXOSOME COMPOSITIONS AND USES THEREOF Publication number: 20220409535 Abstract: The present invention relates to compositions comprising exosomes and biological agents and methods of using the compositions for the delivery of biological
 
Deeksha Vishwamitra
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Brandi Hilder
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen
 
Tara J. Masterson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jaszianne A. Tolbert
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Janssen Research & Development
 
Thomas Renaud
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Christoph Heuck
No Relationships to Disclose
 
Colleen Kane
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
 
Mahesh N. Samtani
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Johnson & Johnson
 
Suzette Girgis
Employment - Janssen; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Bristol Myers Squibb; CSL Behring (I); Janssen Research & Development; Jazz Pharmaceuticals; Lilly
Research Funding - Bristol Myers Squibb (I); CSL Behring (I); Janssen Research & Development; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent on Teclistamab (Janssen) Patent on Talquetamab (Janssen)
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Roche (Inst); Secura Bio (Inst); Takeda (Inst)
Research Funding - 2Seventy bio (Inst); Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); CARsgen Therapeutics (Inst); Cartesian Therapeutics (Inst); Celgene (Inst); Celularity (Inst); crispr therapeutics (Inst); EMD Serono (Inst); Fate Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Incyte (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Oncopeptides; Pfizer; Regeneron; Sanofi/Aventis
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Daniele Ouellet
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen